论文部分内容阅读
腹膜透析是治疗终末期肾衰的有效手段,据统计,1992年全世界有65000多病人接受腹透治疗。 一、腹透和血透的比较 1.死亡率:许多学者用Cox风险比例模型来分析透析病人死亡危险因素,发现CAPD和血透本身对病人死亡的影响并无显著性差别。心血管合并症是透析病人死亡的主要危险因素,我们曾发现,因心血管合并症而死者占CAPD病人死亡的71.4％。2.退出率:指透析方式的改变。以往,由于CAPD腹膜炎发生率高,其退出率
Peritoneal dialysis is an effective treatment of end-stage renal failure, according to statistics, in 1992 there are more than 65,000 patients worldwide received peritoneal dialysis. First, the comparison of peritoneal dialysis and hemodialysis 1. Mortality: Many scholars use the Cox proportional hazards model to analyze the risk factors for mortality in dialysis patients and found no significant difference in the effects of CAPD and hemodialysis on patient mortality. Cardiovascular complications are a major risk factor for mortality in dialysis patients and we have found that 71.4% of those who died of cardiovascular complications died of CAPD. 2. Exit rate: refers to the change of dialysis mode. In the past, due to the high incidence of CAPD peritonitis, its withdrawal rate